Showing results (41-50 of 180) with videos related to

Sort By:
Pageof 18
Revista Espanola De Cardiologia|March 15, 2002
[Cardiac troponin I in perioperative myocardial infarction after coronary artery bypass surgery]Javier de Castro Martínez, Sonia Vázquez Rizaldos, Carlos Velayos Amo, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 16, 2008
Retroperitoneal Castleman's disease with colon cancer. A rare associationCésar Gómez-Raposo, Manuel Nistal, Javier De Castro Carpeño, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 12, 2021
Matching-Adjusted Indirect Comparisons in the assessment of hemato-oncological drugsJosé Manuel Martínez-Sesmero, Javier De Castro-Carpeño, Araceli López-de Las Heras, et al.
Lung Cancer (Amsterdam, Netherlands)|December 14, 2011
A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancerMark J C Nuijten, Javier de Castro Carpeño, Christos Chouaid, et al.
International Journal of Colorectal Disease|April 29, 2011
Colonoscopic perforation: useful parameters for early diagnosis and conservative treatmentJordi Castellví, Felip Pi, Albert Sueiras, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2011
Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and SpainKurt Banz, Helge Bischoff, Matthias Brunner, et al.
Case Reports in Oncology|September 5, 2020
Lung Adenocarcinoma during Pregnancy: 11-Year Follow-UpAngel Acosta Rojas, Ana Collazo-Lorduy, Jordi Remon, et al.
Pathology Oncology Research : POR|November 13, 2008
EPO-R expression patterns in resected gastric adenocarcinoma followed by adjuvant chemoradiation treatmentMaria Sereno, Javier De Castro, Cristóbal Belda-Iniesta, et al.
Lung Cancer (Amsterdam, Netherlands)|August 24, 2010
Societal cost savings through bevacizumab-based treatment in non-small cell lung cancer (NSCLC)Sanja Stanisic, Helge G Bischoff, David F Heigener, et al.
Lung Cancer (Amsterdam, Netherlands)|August 24, 2010
Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancerMark Nuijten, David F Heigener, Helge G Bischoff, et al.
Pageof 18